Professor of Diabetes & Endocrinology, Consultant Physician, & Head of Service in Diabetes,
University hospital birmingham
Prof. Wasim Hanif is a Professor of Diabetes & Endocrinology, Consultant Physician, & Head of Service in diabetes at University Hospital Birmingham. He is the Board Member of Centre for Diabetes Endocrine & Metabolism University of Birmingham & Clinical Advisory Group lead for research in Diabetes & Endocrinology at Institute of Translation Medicine, Birmingham. He is an eminent authority on Diabetes, Obesity, and Ethnic health. He works with several national bodies, and professional groups in the UK. He has been involved with major research projects in diabetes and has published widely. He was selected for Kings Fund Leadership Programme in Diabetes. His research interest includes: diabetic kidney disease, diabetes prevention, management of diabetes in Ramadan, obesity, ethnicity and tackling health inequalities.He is involved as a chief and principal investigator in several international multi-centre trials and was instrumental in setting up UKADS (United Kingdom Asian Diabetes Study). Prof. Hanif has been involved at a parliamentary level to advise the government on issues relating to Diabetes and ethnic health. He is the Chair of the Diabetes Working Group of the world-recognised South Asian Health Foundation (SAHF). Prof. Hanif is a member of the Parliamentary and Stakeholder Diabetes Think Tank advising the All Party Parliamentary Group on Diabetes. His involvement in NICE has been extensive, sitting on advisory NICE Health Technology Appraisal Committee Between 2009 and 2015, and acting as an advisor on many issues including the use of health technologies, definitions of Obesity and Waist circumference in British South Asians, prevention of diabetes in high risk groups, physical activity and type 2 diabetes. He is on the Expert Advisory Committee of Commission of Human Medicine, advising MHRA on new Medicinal agents. He is on the Board of Governors as a Trustee of Diabetes UK, helping in strategy, advocacy, patient empowerment and research to help improve outcomes in people with diabetes in the UK.